Persoanele care au fibroza chistica pot avea probleme respiratorii si afectarea plamanilor. Multi oameni nu stiu ca au gena CFTR. Este o boala autosomal recesiva, ceea ce inseamna ca pot sa fie afectati atat baietii, cat si fetele.
Source: Romanian Journal of Infectious Diseases. The prevalence in patients with cysic fibrosis is controversial.
The paper present generale data about Helicobacter pylori and the particularities of this infection in cystic fibrosis cystic fibrosis paradox. The authors concluded that although the prevalence of Helicobacter pylori and its role in gastroduodenal disease in cystic fibrosis are controversial, however, its role should not be underestimated.
English Copyright of Romanian Journal of Infectious Diseases is the property of Amaltea Medical Publishing House and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.
Timea Învinge Fibroza Chistică 4 Mai Simptomele fibrozei chistice sunt date de productia de mucus lipicios, de consistenta crescuta. Simptomele variaza de la persoana la persoana si nu sunt adeasea evidente in copilarie. Simptomele fibrozei chistice la un sugar sau copil mic includ: - obstructie de intestin subtire numita ileus meconial sau obstructie meconiala specifică nou-născutului - pielea sarata si umeda - inapetenta lipsa poftei de mancareastenia sau scaderea in greutate. Se numeste dezvoltare deficitara failure to thrive - miscari neobisnuite ale intestinelor.
This abstract may be abridged. No warranty is given about the accuracy of the copy.
Users should refer to the original published version of the material for the full abstract. Important User Information: Remote access to EBSCO's databases is permitted to patrons of subscribing institutions accessing from remote locations for personal, non-commercial use.
However, remote access to EBSCO's databases from non-subscribing institutions is not allowed if the purpose of the use is for commercial gain through cost reduction or avoidance for a non-subscribing institution.